In the wake of Advocate Health Care and NorthShore University HealthSystem's proposed merger, America's Health Insurance Plans is leading the charge to prevent this and similar mergers and acquisitions.
In the wake of Advocate Health Care and NorthShore University HealthSystem’s proposed merger, which would form the largest integrated healthcare delivery system in Illinois, America’s Health Insurance Plans (AHIP) is leading the charge to prevent this and similar mergers and acquisitions.
The new Advocate NorthShore Health Partners (ANHP) would serve 3 million patients as well as nearly a quarter of the hospital care market in the Chicago area, according to Crain’s Chicago Business. In some suburbs, ANHP will command as much as 40%. Holding such a large market share would give the new system more leverage in contract negotiations.
According to AHIP, such consolidation only brings greater costs. The organization has taken issue with the idea that health reform means greater consolidation of providers.
“Recognizing the harmful consequences of anticompetitive provider consolidation on consumers and the overall healthcare system, the health plan community is committed to developing innovative ways to improve care management and control costs,” Alicia Caramenico wrote in an AHIP blog post.
Earlier this year ProMedica, based in Ohio, was ordered to unravel its acquisition of St. Luke’s Hospital because the merger would result in higher prices due to less competition in the market, according to Forbes.
The Advocate-NorthShore deal is still subject to review by the Federal Trade Commission, as well the Illinois Health Facilities and Services Review Board.
“Bigger hospitals really only mean bigger bills for patients,” Brendan Buck, vice president of communications at AHIP, told the Chicago Sun-Times. “Consolidation promises greater efficiency, but all that ever materializes is greater costs.”
Caramenico pointed to Partners HealthCare in Boston, a system of 8 hospitals, which is large enough to drive up healthcare prices. The health system’s prices are 60% higher than competing hospitals that are providing the same services. Ultimately, that pushes up the cost for everyone.
Real-World Data Show Sotorasib Effective for NSCLC With KRAS Mutation
May 18th 2024Data from real-world and clinical-trial settings on frontline monotherapy treatment with the KRAS inhibitor sotorasib both show similar progression-free survivals and a high likelihood that the treatment’s efficacy is not affected with dose reduction.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More